Discussion forum for Pharma Quality events, Regulatory Actions

Warning letters, 483s, Recalls, Import Alerts, Audit observations

Warning letter / Centrient India / MARCS

USFDA Warning letter to Centrient India (Toansa, Punjab FEI 3004497364) in December 2022 cite method

Qvents
April 18, 2023

Warning letter / Centrient India / MARCS

USFDA Warning letter  to Centrient India (Toansa, Punjab FEI 3004497364) in December 2022 cited deficiencies in investigating

Qvents
April 18, 2023

Warning letter / Glenmark, Goa, India /F

USFDA issued Warning letter to Glenmark, Goa, India facility (FEI 3004672766), cites lapses in procedure

Qvents
April 18, 2023